Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians
about
The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerPersonalised cancer medicinePharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyondA comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [(11)C]erlotinib and [(18)F]afatinib in lung cancer-bearing mice.Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy.Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancer.A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignanciesNotching tumor: Signaling through Notch receptors improves antitumor T cell immunity.UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivoA multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer.ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations.Revealing protein networks and gene-drug connectivity in cancer from direct information.ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption.EGFR targeted therapy in lung cancer; an evolving storyA review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer.Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A Review.Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.Extended release delivery of erlotinib glutathione nanosponge for targeting lung cancer.Rise of Deep Learning for Genomic, Proteomic, and Metabolomic Data Integration in Precision MedicineProtegrin 1 Enhances Innate Cellular Defense via the Insulin-Like Growth Factor 1 Receptor PathwayNotch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLCGenomics of adult and pediatric solid tumors
P2860
Q26749110-9072B6D2-95F7-4D45-974D-B062A446BAACQ26991908-3E95E783-E20D-4E15-A211-2AB48C864759Q28080730-05A7D094-4ECF-475B-AC06-C59120746999Q35267340-330CCA88-ED4D-4935-9814-9898E446F4E1Q36296504-FDE99E89-CE44-4142-9CCA-5ECBCC69715CQ36502935-DCF5A33C-1072-4EED-9968-73527D9447A3Q36748775-4AAD4F05-D711-4F06-BA65-E78F2153F785Q37012585-B290B6CD-6C6A-44AB-807F-01CFD1E6F765Q37297144-96EE032D-EED8-4DE6-833F-E8FEB5849A60Q37417712-93733D93-051D-4031-94E4-33C7B9DB6275Q37668848-1678D49C-77BB-43E9-817A-683853A95B0DQ38048501-03384C44-DFB7-4757-A423-36F1E1F60DADQ38721721-3BB39FAB-9881-4315-A927-2D4C24554B56Q38762359-D799F485-D9F4-4171-8D40-80F9499E73FFQ41645505-18DC4EF0-3FA7-4640-AD19-9D2D92C1A7ACQ42322394-D430AF0C-615B-4B04-99B6-3F4E32AB2367Q45949842-B0158F2C-FDE3-4822-B194-7E9ADE48CD48Q45973958-E0BD9A7A-8553-41E8-80AD-A6DC5085E1B3Q52568478-9B783D00-788F-482B-95C7-D72D4CBDD084Q53134314-2AD4DEFB-4C91-47C1-BFA3-D5146A387AB9Q57168536-397204AA-8638-48BB-AD4B-4ACBFCA9E3DBQ57490046-5D234C79-1387-49BA-9CEB-7FF563251340Q58790384-F21DF64A-DD2D-4A24-B0ED-CD01BFD82564Q58804574-AB2C18A8-3D66-4922-B57D-C54F2AF8E79F
P2860
Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Erlotinib in the treatment of ...... ncer: an update for clinicians
@ast
Erlotinib in the treatment of ...... ncer: an update for clinicians
@en
type
label
Erlotinib in the treatment of ...... ncer: an update for clinicians
@ast
Erlotinib in the treatment of ...... ncer: an update for clinicians
@en
prefLabel
Erlotinib in the treatment of ...... ncer: an update for clinicians
@ast
Erlotinib in the treatment of ...... ncer: an update for clinicians
@en
P2093
P2860
P356
P1476
Erlotinib in the treatment of ...... ncer: an update for clinicians
@en
P2093
Caicun Zhou
Gerald Schmid-Bindert
Yongsheng Wang
P2860
P356
10.1177/1758834011427927
P577
2012-01-01T00:00:00Z